Cuproptosis: a novel mechanism linking placental metabolic stress to trophoblast injury in preeclampsia - Scorecard - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Cuproptosis: An Emerging Mechanism Connecting Metabolic Stress in the Placenta to Trophoblast Damage in Preeclampsia

  • By

  • Ling Liu

  • Baoxiang Xing

  • Yan Zhang

  • September 9, 2026

Share

Clinical Scorecard: Cuproptosis: An Emerging Mechanism Connecting Metabolic Stress in the Placenta to Trophoblast Damage in Preeclampsia

At a Glance

CategoryDetail
ConditionPreeclampsia
Key MechanismsCuproptosis linked to trophoblast injury via copper-dependent processes and metabolic stress.
Target PopulationPregnant women, particularly those in the third trimester.
Care SettingObstetric care and maternal-fetal medicine.

Key Highlights

  • Preeclampsia complicates 2-8% of pregnancies, leading to significant maternal and perinatal morbidity.
  • Cuproptosis is a newly recognized regulated cell-death process linked to copper metabolism.
  • Higher serum copper concentrations have been observed in women with preeclampsia.
  • Lactate accumulation in placentas activates pathways leading to trophoblast cuproptosis.
  • Copper transport dysregulation may be a key factor in placental dysfunction in preeclampsia.

Guideline-Based Recommendations

Diagnosis

  • Monitor serum copper levels and thiol levels in pregnant women suspected of preeclampsia.

Management

  • Investigate copper transport mechanisms and their role in trophoblast function.

Monitoring & Follow-up

  • Assess placental health and maternal serum copper levels throughout pregnancy.

Risks

  • Increased risk of maternal and perinatal morbidity associated with preeclampsia.

Patient & Prescribing Data

Women in the third trimester of pregnancy.

Further research needed on copper handling and its implications for trophoblast health.

Clinical Best Practices

  • Consider the role of metabolic stress and copper dysregulation in managing preeclampsia.
  • Utilize transcriptomic profiling to identify potential biomarkers for preeclampsia.

Related Resources & Content

Original Source(s)

Related Content